Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05743595
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-02-14
Brief Title:
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed Unmethylated Glioblastoma
Sponsor:
Organization:
Washington University School of Medicine